Metraipolis › archive › dc_537f7ee53193

Clinical application of synovial fluid albumin-to-globulin ratio as a novel biomarker in diagnosing chronic periprosthetic joint infection — Europe PMC PMID:42256213

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42256213
DOI
10.3389/fcimb.2026.1750599
License (as archived)
solo-consultazione
Archived
2026-11-01T09:46:37.389Z
SHA-256 of the archived text
ebb0f1241e2ef34a0d6c42c35b484e00612ae6cc8b3abbd38ca904f2368b5183
Stable URL of this page
https://metraipolis.com/documento/dc_537f7ee53193

How to cite

Clinical application of synovial fluid albumin-to-globulin ratio as a novel biomarker in diagnosing chronic periprosthetic joint infection — Europe PMC PMID:42256213 — Europe PMC (en), https://europepmc.org/article/MED/42256213 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_537f7ee53193 (Metraipolis archive dc_537f7ee53193, sha256 ebb0f1241e2ef34a0d6c42c35b484e00612ae6cc8b3abbd38ca904f2368b5183)
BibTeX
@misc{dc537f7ee53193,
  title = {Clinical application of synovial fluid albumin-to-globulin ratio as a novel biomarker in diagnosing chronic periprosthetic joint infection — Europe PMC PMID:42256213},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42256213},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_537f7ee53193; sha256 ebb0f1241e2ef34a0d6c42c35b484e00612ae6cc8b3abbd38ca904f2368b5183},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42256213. Agents can read the archived copy with the MCP tool read_document.